Email updates

Keep up to date with the latest news and content from BMC Proceedings and BioMed Central.

This article is part of the supplement: Abstracts of the 16th International Charles Heidelberger Symposium on Cancer Research

Open Access Poster presentation

NMR metabonomic study of lung cancer: metabolic profiling of tissues

Cláudia M Rocha1*, António S Barros2, Ana M Gil1, Brian J Goodfellow16, Isabel M Carreira36, João Bernardo46, Ana Gomes46, Vítor Sousa456, Lina Carvalho456 and Iola F Duarte16

Author Affiliations

1 CICECO, Department of Chemistry, University of Aveiro, Aveiro, Portugal

2 QOPNA, Department of Chemistry, University of Aveiro, Aveiro, Portugal

3 Cytogenetics Laboratory and CNC, Faculty of Medicine, University of Coimbra, Coimbra, Portugal

4 University Hospitals of Coimbra, Coimbra, Portugal

5 Institute of Pathological Anatomy, Faculty of Medicine, University of Coimbra, Coimbra, Portugal

6 CIMAGO, Faculty of Medicine, University of Coimbra, Coimbra, Portugal

For all author emails, please log on.

BMC Proceedings 2010, 4(Suppl 2):P66  doi:10.1186/1753-6561-4-S2-S66


The electronic version of this article is the complete one and can be found online at: http://www.biomedcentral.com/1753-6561/4/S2/P66


Published:24 September 2010

© 2010 Rocha et al; licensee BioMed Central Ltd.

Poster presentation

This work aims to evaluate the potential of 1H Nuclear Magnetic Resonance (NMR) spectroscopy combined with multivariate statistics (metabonomics) for finding malignancy biomarkers in lung tissue and discriminating between different tumour histological types. Paired tissue samples from 32 patients with primary lung cancer were directly analysed by 1H High Resolution Magic Angle Spinning (HRMAS) NMR (500 MHz) and the spectral profiles subjected to Principal Component Analysis (PCA) and Partial Least Squares Regression Discriminant Analysis (PLS-DA). Tumor and control tissues were clearly discriminated in the PLS-DA model with 95% sensitivity and 100% specificity. In agreement with previous work [1], the metabolites giving rise to this separation were mainly lactate, glycerophosphocholine, phosphocholine, taurine, glutathione and uridine di/tri-phosphate (elevated in tumours), and glucose, phosphoethanolamine, acetate, lysine, methionine, glycine, myo- and scyllo-inositol (reduced in tumours compared to control tissues). Regarding differentiation of histological types, carcinoid tumors showed a distinct profile characterized by very low lipid levels, the presence of broad signals possibly arising from oligopeptides, decreased PC/GPC ratio and increased taurine and ascorbate levels. Epidermoid tumors could also be differentiated from adenocarcinomas due to increased lipids, lactate, creatine and GSH and decreased taurine, choline and PC. The biochemical information retrieved, not available by conventional histopathology, may provide additional criteria for improving clinical decisions and potentially aid in the differential diagnosis of lung tumors.

References

  1. Rocha C, Barros AS, Gil AM, Goodfellow BJ, Humpfer E, Spraul M, Carreira IM, Melo JB, Bernardo J, Gomes A, Sousa V, Carvalho L, Duarte IF: Metabolic profiling of human lung cancer tissue by 1H High Resolution Magic Angle Spinning (HRMAS) NMR spectroscopy.

    J Proteome Res 2010, 9:319-332. PubMed Abstract | Publisher Full Text OpenURL